SCHEMBL7188680

SCHEMBL7188680

COC(=O)c1ccc(NC2CCC(O)CC2)c(N)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.60
MAPT P10636 5/20 0.50
KDM4E B2RXH2 5/20 0.50
ALDH1A1 P00352 4/20 0.50
GAA P10253 3/20 0.50
HSD17B10 Q99714 2/20 0.50
HPGD P15428 2/20 0.50
GLA P06280 1/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
ATM Q13315 1/20 0.50
NPC1 O15118 4/20 0.48
RAB9A P51151 3/20 0.48
PTGER4 P35408 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ERAP2 Q6P179 3/20 0.44
LNPEP Q9UIQ6 3/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21310999 1.00 ALOX15 (0.60) ALOX15MAPTKDM4EALDH1A1GAA
SCHEMBL7188685 1.00 ALOX15 (0.60) ALOX15MAPTKDM4EALDH1A1GAA
SCHEMBL23971034 0.94 ALOX15 (0.66) ALOX15MAPTKDM4EALDH1A1GAA
SCHEMBL27218080 0.89 ALOX15 (0.74) ALOX15MAPTKDM4EALDH1A1GAA
SCHEMBL5836935 0.89 ALOX15 (0.70) ALOX15MAPTKDM4EALDH1A1GAA
SCHEMBL5065680 0.88 ALOX15 (0.77) ALOX15MAPTKDM4EALDH1A1GAA
SCHEMBL2028039 0.87 ALOX15 (0.80) ALOX15GAARAB9APTGER4
SCHEMBL2028037 0.87 ALOX15 (0.80) ALOX15GAARAB9APTGER4
SCHEMBL7190438 0.86 PRKCI (0.56) ALOX15MAPTKDM4EALDH1A1GAA
SCHEMBL21311001 0.85 ALOX15 (0.59) ALOX15MAPTKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6582351-B1 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-24 US disclosed
EP-1196391-A1 BENZIMIDAZOLONE DERIVATIVES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-17 EP disclosed
WO-2001005770-A1 BENZIMIDAZOLONE DERIVATIVES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-25 WO disclosed